- Arrowhead, Sarepta launched in huge deal worth $11.38 billioninvestor's business daily
- Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA Programsbusiness wire
- Sarepta to pay Arrowhead $500M+ in licensing deal for siRNA-based therapiesyahoo finance
- Sarepta targets up to $10B in Arrowhead to diversify pipeline with RNA drugsbiospace
- Sarepta licenses Arrowhead's RNA-based rare disease pipeline, promising big biobucksendpoint news